09:00-09:15

                   Opening Ceremoney

Keynote Forum

Increased telomerase improves motor function and alpha-synuclein pathology in a transgenic mouse model of Parkinson’s disease associated with enhanced autophagy

Title - Increased Telomerase Improves Motor Function And Alpha-synuclein Pathology In A Transgenic Mouse Model Of Parkinson’s Disease Associated With Enhanced Autophagy

Speaker Abstract

Protective Effects Of The Telomerase Protein TERT Have Been Shown In Neurons And Brain. We Previously Demonstrated That TERT Protein Can Accumulate In Mitochondria Of Alzheimer’s Disease (AD) Brains And Protect From Pathological Tau In Primary Mouse Neurons. This Prompted Us To Employ Telomerase Activators In Order To Boost Telomerase Expression In A Mouse Model Of Parkinson’s Disease (PD) Overexpressing Human Wild Type α-synuclein. Our Aim Was To Test Whether Increased Tert Expression Levels Were Able To Ameliorate PD Symptoms And To Activate Protein Degradation. We Found Increased Tert Expression In Brain For Both Activators Which Correlated With A Substantial Improvement Of Motor Functions Such As Gait And Motor Coordination While Telomere Length In The Analysed Region Was Not Changed. Interestingly, Only One Activator (TA- 65) Resulted In A Decrease Of Reactive Oxygen Species From Brain Mitochondria. Importantly, We Demonstrate That Total, Phosphorylated And Aggregated α-synuclein Were Significantly Decreased In The Hippocampus And Neocortex Of Activator-treated Mice Corresponding To Enhanced Markers Of Autophagy Suggesting An Improved Degradation Of Toxic α-synuclein. We Conclude That Increased Tert Expression Caused By Telomerase Activators Is Associated With Decreased α-synuclein Protein Levels Either By Activating Autophagy Or By Preventing Or Delaying Degradation Mechanisms Which Are Impaired During Disease Progression. This Encouraging Preclinical Data Could Be Translated Into Novel Therapeutic Options For Neurodegenerative Disorders Such As PD.

Speaker Biography

Dr. Saretzki Was Born In Berlin, Graduated From Sankt Petersburg(Russia) University 1982 And Did HerPhD At The Department Of Genetics At The Humboldt-University Berlin (Germany) In 1990. Since 1990 She Was Involved In Ageing Research And Worked On Telomeres, Telomerase, Oxidative Stress, DNA Damage And Cellular Senescence. Since 2001 She Worked At Newcastle University (UK) Where She Became A Lecturer In Ageing Research In 2002. In Particular, Her Research Interest Were Functions Of Telomerase In Cancer And Stem Cells As Well As Non-canonical Functions Of The Telomerase Protein TERT In Mitochondria. She Extended This Work To Non-canonical Functions Of TERT In Brain With An Interest In Neurodegenerative Diseases And Is Now Retired. She Published More Than 100 Papers And Has An H-index Of 52.

Listen to this article

Neuronaprotective effect of Artemisinin and its derivatives (Arts) and their implication in the treatment of Alzheimer’s disease

Title - Neuronaprotective Effect Of Artemisinin And Its Derivatives (Arts) And Their Implication In The Treatment Of Alzheimer’s Disease

Speaker Abstract

Alzheimer's Disease (AD), Characterized By The Progressive Loss Of Cognitive Function, Is The Most Common Neurodegenerative Disorder. It Is Marked By The Occurrence Of Neuronal Loss, The Accumulation Of β-amyloid (Aβ) Plaques And Neurofibrillary Tangles. AD Etiology Is Still Unknown, And Currently There Is No Effective Treatment To Cure Or Prevent It. Artemisinin And Its Derivatives Are Safe And Effective Antimalarials, Which Have Been Used For Decades In The Clinic Saving Millions Of Lives. We Have Recently Discovered That, Artemisinin Has A Neuroprotective Effect. Since It Is Affordable, Safe And Able Tocross The Blood-brain Barrier, This Discovery Offers New Promising Therapeutic Indications For Artemisinin In Diseases Of The Central Nervous System. We Have Found That Artemisinin/artemether Promoted The Survival Of Several Neuronal Cells. In Fact, Pretreatment Of PC12 Cells With Artemisinin/artemether Significantly Inhibited Aβ1-42-induced Cell Death, Reduced Intracellular Reactive Oxygen Species (ROS) Production, Prevented Mitochondrial Membrane Potential Loss And Reduced LDH Release And Caspase 3/7 Activation. Western Blot Analysis Revealed That Artemisinin/artemether Stimulatedthe Phosphorylation/activation Of ERK, AMPK And CREB While Inhibition Of The ERK/ AMPK Signaling Pathways, By EitherERK Pathway Inhibitor PD98059/AMPK Inhibitor Compound C, Reduced The Expression Of ERK/AMPK With SiRNA Blocking The Protective Effect Of Artemisinin/ Artemether. Similar Results Were Obtained In Other Neuronal Cells And Primary Cultured Neurons. These Findings Suggest That Artemisinin/ Artemether Is A Potential Neuroprotective Agent That Inhibits Various Toxin-induced Cell Death By Activating Signaling Pathways Such As ERK/AMPK/ Autophagy. In Addition, Artemisinin/artemether Significantly Improved The Cognitive Impairment And Reversed Several Pathological Changes In AD Mice. It Reduced Neuronal Cell Death, Aβ Deposit And Tau Phosphorylation. These Findings Support The Potential Application Of Artemisinin And Its Derivatives On The Prevention And Treatment Of Neurodegenerative Diseases Such As AD

Speaker Biography

Dr. Wenhua Zheng, Professor, Principle Investigator In Faculty Of Health Science, University Of Macau, Leading A Group Of Scientists Working On Aging And Neuronal Degenerative Disorders. He Is A Section Editor For Encyclopedia Of Gerontology And Population Aging; A Lead Guest Editor And Editor For Several Journals. Grant Reviewer For NSFC, Poland And CIHR In Canada. He Is An Honorary Professor At The University Of Queensland (QS45) And An Adjunct Professor/ Visiting Prof At RMIT University And Other Universities. Dr Zheng Has Published >150 Papers Which Have Been Cited Over 6500 Times

Listen to this article

Pharmacology profile of f17464, a dopamine D3 receptor preferential antagonist potential antipsychotic

Title - Pharmacology Profile Of F17464, A Dopamine D3 Receptor Preferential Antagonist Potential Antipsychotic

Speaker Abstract

F1 7 4 6 4 ( N - ( 3 - { 4 - [ 4 - ( 8 - O X O - 8 H - [ 1 , 3 ] - D I O X O L O - [ 4 , 5 - G ] - C H R O M E N - 7 - Y L ) - B U T Y L ] - P I P E R A Z I N - 1 - Y L } - P H E N Y L ) - Methanesulfonamide, Hydrochloride) Is A New Potential Antipsychotic With D3 Over D2 Dopamine Receptor Preferential Antagonism And 5-HT1A Receptor Partial Agonism Properties. Its Selective D3 Receptor Occupancy Has Been Demonstrated In A Human PET Imaging Study (Slifstein Et Al., 2020 Psychopharmacology , 237:519-527). Reported F17464 Behavioural Work (Sokoloff And Le Foll, 2017 Eur J Neurosci 45(1):2-19.) Has Been Here Expanded To Show The Compound Target Engagement, Neurochemical Properties , Effects On NMDA - Glutamatergic Alterations And Its Beneficial Effects In A Rodent Model For Autism (Cosi Et Al., 2021 Eur J Pharmacol890:173635). F17464 Exhibits High Affinity For Human Dopamine Receptor Subtype 3 (hD3) (Ki = 0.17 NM) And The Serotonin Receptor Subtype 1A (5-HT1A) (Ki = 0.16 NM) And A >50 Fold Lower Affinity For The Human Dopamine Receptor Subtype 2 Short And Long Form (hD2s/l) (Ki = 8.9 And 12.1 NM, Respectively). [14C]F17464 Has A Slower Dissociation Rate From HD3 Receptor (t1/2 = 110 Min) Than From HD2s Receptor (t1/2 = 1.4 Min) And Functional Studies Demonstrate That F17464 Is A D3 Receptor Antagonist, 5-HT1A Receptor Partial Agonist. In Human Dopaminergic Neurons F17464 Blocks Ketamine Induced Morphological Changes, An Effect D3 Receptor Mediated. In Vivo F17464 Target Engagement Of Both D2 And 5-HT1a Receptors Is Demonstrated In Displacement Studies In The Mouse Brain. F17464 Increases Dopamine Release In The Rat Prefrontal Cortex And Mouse Dorsal Striatum, Frontal Cortex, N.accumbens, Olfactory Tubercle And Attenuates The MK801-induced Decrease Of C-fos MRNA In C-fos Medium Expressing Neurons In Mouse Cortical And Subcortical Regions. F17464 Also Rescues Valproate Induced Impairment In A Rat Social Interaction Model Of Autism. F17464 Dose Range Used Both In Rats And Mice Was 0.32– 2.5 Mg/kg I.p. The Preferential D3 Antagonist F17464, Is Potential Antipsychotic That Shows Promise For Treating The Cognitive And Negative Symptoms Of Schizophrenia And Possibly Of Autism.

Speaker Biography

Biologist And Pharmacologist, Biochemist By Training, With A Master In Science From The University Of Florence, Italy, And A PhD In Molecular Pharmacology From The University Of Toulouse, France, 1997, Cristina Cosi Has An Extensive Working Experience In The Neuroscience Research Field, Mostly In Industry At Pierre Fabre, France, But Also In Academic Environments, In Italy, University Of Florence And Verona, And US, NIH. She Has Focused Her Career On The Understanding Of Neurodegenerative Processes And Mechanisms Of Neuronal Plasticity In Order To Find Medications That Might Be Beneficial Against Neurodegenerative And Neurodevelopmental Diseases And Pain.

Listen to this article

Phruek Daengbubpha

Title- Comparing methods of adenosine administration in paroxysmal supraventricular tachycardia: A pilot randomized controlled trial

Speaker Abstract

Study objective: Adenosine intravenous is the recommended treatment for paroxysmal supraventricular tachycardia (PSVT). There is no official recommended method of giving adenosine. We aim to compare the success rate between the standard and alternative method of first dose intravenous adenosine in PSVT. Methods: A pilot parallel randomized controlled study was conducted in the Emergency Department (ED) of a tertiary care hospital. Eligible patients were stable PSVT patients. We used block randomization and divided them into two groups, the standard method (double syringe technique of 6 milligrams adenosine), and the alternative method (similar to standard method, then immediately followed by elevating arm to 90 degrees perpendicular to a horizontal plane for 10 seconds). Primary outcome is the success rate of electrocardiogram (ECG) response which demonstrated termination of PSVT (at least 2-fold of the RR-interval widening or sinus rhythm conversion). Secondary outcomes are complications within 1 minute after injection. Results: We allocated 15 patients in each group and analysed as intention-to-treat. The success rate was 86.7 % in the alternative group and 80% in the standard group (risk difference 6.7%, 95% confidence interval -19.9 to 33.2%, P value 1). Complications within 1 minute after adenosine injection were also similar in both groups, 14 of 15 patients (93%) in each group have no complication, without significant difference. Conclusion: No evidence difference between alternative and standard method, in terms of the success rate of ECG response and complications within 1 minute after adenosine injection. A further definitive study is required.

Speaker Biography

Phruek Daengbubpha received the Doctor of Medicine degree in 2014 from Chiang Mai university and recently graduated from Emergency Department, Faculty of Medicine, Chiang Mai University in 2021.After graduation, he has been working as Emergency Physician in Chom Thong Hospital, where is located 40 miles away from Chiang Mai. This research has done when he was training as a resident physician. Because in Thailand, they were taught to administer adenosine for SVT by elevate the arm. So, he was inspired and want to find out that is it possible if we do not elevate the arm. And what will be the result from this method.

Listen to this article

Liwen Wu

Title- Autoimmune glial fibrillary acidic protein astrocytopathy in children: A retrospective analysis of 35 cases

Speaker Abstract

Objective: To analyze the clinical manifestations, imaging, electroencephalography, treatment, and prognosis of autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A) in children. Methods: There were 40 children positive for GFAP-immunoglobulin (Ig)G antibodies in the serum and/or the cerebrospinal fluid. Five children who were only positive for GFAP-IgG antibodies in serum were excluded, and the remaining 35 children were diagnosed with autoimmune GFAP-A. The clinical data derived from the 35 children were retrospectively analyzed. Results: A total of 35 children, including 23 males and 12 females with a mean age of 6.3 ± 0.6 years, manifested clinical symptoms of fever (62.9%), headache (42.9%), convulsions (42.9%), abnormal mental behavior (51.4%), disorders of consciousness (54.3%), visual disturbance (22.9%), ataxia (11.4%), paralysis (40%), and autonomic dysfunction (25.7%). One child exhibited only the clinical symptom of peripheral facial nerve palsy. Eleven out of 35 children were also positive for other antibodies. In addition to the common overlapping autoimmune syndromes, one case of autoimmune GFAP-A also manifested as Bickerstaff’s brainstem encephalitis. Linear periventricular enhancement upon MRI was significantly less frequent in children (8.5%) than in adults. In pediatric patients, MRI contrast enhancement was principally seen in the meninges and brain lobes. Although repeated relapse (17.1%) and sequelae symptoms (20%) occurred in some cases, most children showed a favorable prognosis. Spearman’s rank correlation showed that the antibody titer was not significantly associated with the severity of the initial disease conditions. Conclusions: The disease diagnosis in children seropositive for GFAP antibodies only should receive a comprehensive diagnosis based on their clinical symptoms, imaging, electroencephalographic characteristics, and treatment responses. Some patients withrelapses should receive repeated gamma globulin and corticosteroid therapy or the addition of immunosuppressants to their therapeutic regimen, and slow-dose tapering of corticosteroids and extended treatment are recommended for patients with overlapping autoimmune syndromes

Speaker Biography

Wu Liwen, Doctor of pediatric neurology, associate professor, postgraduate supervisor. Deputy head of Neuroyouth Group of Scientific Branch of Chinese Medical Association, member of Youth Committee of China Anti Epilepsy Association, member of drug treatment professional committee of China Anti Epilepsy Association, and chairman of the Whole Course Management Committee of Nervous System Diseases of Hunan Health Management Society. Dr. Wu takes charge of Presided over 3 Projects from the National Natural Science Foundation of China, 1 Project from the Natural Science Foundation of Hunan Province and 1 Project supported by the Health Commission. She has published more than 30 academic papers as the first author/corresponding author; She was awarded the "May 4th Youth Medal" of Hunan Health Commission, Young Talents in Hunan and the Most Beautiful Doctor in Hunan Province.

Listen to this article

Yuki Hamada

Title- Placenta-derived drug laennec and porcine improve hereditary hemochromatosis without phlebotomy and ameliorate neurological symptoms of wilson disease through the action of “hepcidin inducer”

Speaker Abstract

Human hepcidin made by hepatocytes controls extracellular iron by regulating its intestinal absorption, recycling by macrophages, and release from storage spaces. Recent studies indicate that hepcidin deficiency underlies most known forms of hereditary hemochromatosis (H.H). Case1 (H.H): 44years-old male patient who developed type2 diabetes mellitus(T2DM) had elevated serum ferritin (SF) level (10,191ng/ml). Liver biopsy revealed remarkable iron deposition in hepatocytes and relatively advanced fibrosis (F3). Chromosomal analysis confirmed the presence of transferrin receptor type 2(TfR2) mutations. Infusion with Laennec has been done for 84 months as the substitute for the repeated phlebotomy. At the end of the treatment, the serum ferritin level was decreased to 428.4ng/ml (significantly lower than the started level). HbA1c also improved with the same or lower dose of insulin (8.86.8%). Plural liver biopsies revealed remarkable improvements in the grade of both iron deposition and fibrosis (F3F1) of the liver tissue. Case2(Wilson Disease):34years-old male patient who was diagnosed as Wilson Disease (W.D) when he was 10 years old. Impaired biliary excretion leads to accumulation of copper in the liver. This copper promotes the generation of free radicals and cell damage. With a histidine residue of hepcidin at position 3, this region also has the potential to bind bivalent metal ions such as copper. The high affinity of hepcidin for copper suggests that hepcidin could bind copper in vivo.Here we showed that infusion with Laennec which was elucidated to induce hepcidin enhanced the urinary excretion of copper and improved neurological signs of W.D remarkably. The discovery of hepcidin and its role in iron and copper metabolism could lead to novel therapies for H.H. and W.D. The placenta-derived Laennec (parenteral)and Porcine (oral) which act as the “hepcidin inducer” actually improved iron overload of H.H patient without utilizing sequential phlebotomy. These drugs also could improve the neurological symptoms of W.D through the action of hepcidin inducer.

Speaker Biography

Yuki HAMADA Graduated from School of Medicine, Hokkaido University in 1975. From1975-1977 He was medical trainee at Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan followed by Lecturer, Gastroenterology and Hepatology Department, Hokkaido University in 1977-1989. Research Fellow, Faculty of Life Science (Prof.F.L.Bygrave), Australian National University in 1988-1989, 1991. Manager, Gastroenterology section, National Nishi-Sapporo hospital1989-1998 and at present President, HAMADA Clinic for Hepatology and Gastroenterology from1998. He is having membership of International Association for the Study of the Liver, membership of the Japan Society of Hepatology, Medical Specialist of the Japan Society of Hepatology, Board Certified Physician of the Japan Society of Internal Medicine, Medical Specialist of the Japanese Society of Gastroenterolog, Medical Specialist of Japan Gastroenterological Endoscopy Society, Medical Specialist of the Japan Geriatrics Society and Medical Specialist of the Japan Society of Ultrasonic and Medicine

Listen to this article

Feng Xie

Title- Transcriptome analysis of large to giant congenital melanocytic nevus reveals cell-cycle arrest and immune evasion: Identifying potential targets for treatment

Speaker Abstract

Background: Large to giant congenital melanocytic nevus (lgCMN) are cutaneous benign tumors that develop during embryogenesis. A large number of lgCMN patients are ineligible for surgical treatment, hence the urgent need for developing pharmacological treatment. Clinically, tumorigenesis and progression mostly come to a halt after birth, resulting in homeostasis of growth arrest and survival. Numerous studies on whole-genome or whole-exome sequencing in lgCMN have been reported to clarify its etiology. However, transcriptome sequencing is still lacking in lgCMN. Objective: Through comprehensive transcriptome analysis, this study aimed to elucidate the ongoing regulation and homeostasis in lgCMN and identify potential targets for treatment.

Speaker Biography

Feng Xie is a Associate professor in Plastic & Reconstructed Surgery department in Ninth Hospital affiliated by medical school of Shang Hai Jiao Tong University. He obtained the both his Doctor degree and PhD degree in Shang Hai JiaoTong Universityin 2006. He is engaged in treatment of Congenital giant naevus for more than 10 years. The department of Plastic & Reconstructive surgery of Ninth hospital is the most famous plastic center of China. It has 300 beds and more than 100 physicians in the department. Dr. Xie has engaged in Plastic surgery for more than twenty years. He usually use tissue expander to treat giant naevus. However, there are some patients with huge naevus that can not be treated using tissue expander. To solve this problem Dr. Xie is engaged in the study to treat the congenital giant naevus with target drug or immunotherapy. He has published over 20 English papers in this field.

Listen to this article

Effrosyni Koutsouraki

Title- Cerebrospinal and serum biomarkers in a Multiple Sclerosis cohort

Speaker Abstract

The target of early and efficient treatment in patients with multiple sclerosis (MS)is hampered by a lack of prognostic biomarkers that can predict disease progression, severity, and responses to treatment. The scope of the study is to evaluateneuron cytoskeletal and astroglial biomarkers in the cerebrospinal fluid (CSF) and serum(tau, phospho-tau and glial fibrillary acidic protein(GFAP) and correlate with clinical characteristics of MS patients. 87 MS patients (aged 41.1+-11.96) enrolled in the study and 21 controls (aged 44.17 +-12.8). The female/male ratio was 8 females/12males in the controls and 64 females/20males in the patients’ group. From the patients’ cohort 86% (75 patients) were relapsing forms and 14% (12 patients) were progressive forms of the disease. From the total sample 60 patients had disease duration more than a year and 48 less or equal to 1 year. CSF levels of b-amyloid, tau, phospho tau and GFAP were determined using enzyme-linked immunosorbent assay. A significant difference was evident in the levels of phospho tau181 in the CSF of patients (p=0.03) with phospho tau median 34.5 (INQ 22-89) in the relapsing groups and phospho tau median 40.4 (INQ 26-267) in the progressive one. In a linear regression model a potential association was revealed between GFAP serum and Expanded Disability Status Scale change from baseline, with a negative association between GFAP serum levels and EDSS change (b=-2.95;95%CI:from-4.58to-1.32;p=0.003), adjusting for age. EDSS score showed correlation with age (ρ=0.26, p=0.005). Phospho tau proved the most important biomarker to discriminate between relapsing and progressive forms on multiple sclerosis patients. More studies are needed to validate the results, but our study provides preliminary evidence of CSF phopsho t as potential end point surrogate biomarker of progressive MS, GFAP serum as a potential biomarker of relapse.

Speaker Biography

Effrosyni Koutsouraki is an associate Professor of Neurology – Neuroimmunology, Aristotle University, Thessaloniki, Greece. She is also a visiting Senior Investigator in the Cyprus Institute of Neurology and Genetics, Visiting Professor in the Frederick University (Cyprus) and Visiting Professor in Cyprus School of Molecular Medicine (Cyprus). From 2004 up to now: Head of the Outpatient Clinic for Multiple Sclerosis, from 2003 – 2011& 2020 up to now: Outpatient Clinic for Dementia- Alzheimer’s disease, 2007- 2017: Head of the Laboratory of Neuroimmunology. She was a part of Laboratory of Neuropathology at the Eppendorf Hospital, Hamburg, Germany, 1996, Laboratory of Biochemistry and Molecular Biology, Pasteur Research Institute, 2010 and Institute of Neurology and Genetics, 2016-2017 . She is an invited speaker >80 conferences and won around 16 Awards and Honorary Titles.

Listen to this article

 
 13:10-14:00 Intermission & Lunch Break

Veronica Dwarika

Title- Trauma survivors’ experiences of kundalini yoga in fostering posttraumatic growth

Speaker Abstract

Background: The prevalence of traumatic events in South Africa is considerably high due to a history of political violence and the ongoing cycle of interpersonal, community-based, and socioeconomic violence. While conventional therapeutic techniques have been found to support trauma survivors in the local context, alternative approaches that focus on the mind- body connection have become increasingly popular. However, studies reporting on the use of these approaches remain scarce Objective: This study aimed to add to the body of knowledge on yoga as a non-conventional therapy to support trauma survivors and foster posttraumatic growth. Semi-structured interviews were conducted with a sample of seven Kundalini yoga practitioners who had been exposed to trauma Method: Semi-structured interviews were conducted with a sample of seven Kundalini yoga practitioners who had been exposed to trauma Results: A thematic analysis confirmed that Kundalini yoga was beneficial in fostering posttraumatic growth. Conclusion: Overall, the study findings, evidence a pocket of success in relation to value of such an intervention within a low socio economic black South African context.

Speaker Biography

Dr Veronica Dwarika is the senior lecturer at the University of Johannesburg. She is the Deputy HoD in the department of Educational Psychology. She is involved with teacher training at undergraduate and postgraduate levels. She is involved at masters level with the training of student psychologist to become educational psychologist. She also co-ordinates the Professional Doctorate program in Educational Psychology. Her areas of research focus on trauma and resilience, trauma informed care, positive behaviour supports, as well as therapeutic interventions for children, parents and communities. She is involved in local projects to enhance the delivery of psychological therapeutic interventions to support disadvantaged communities.

Listen to this article

Susana Aires de Sousa

Title- The impact of neuroscience in criminal law: The concept of culpability

Speaker Abstract

On the basis of clinical examples and experiments, neuroscientist have argued that the human mind – its emotions and its thoughts – develops according to positive and deterministic laws that occur before the consciousness of a decision. The search for consciousness is explained by neuronal causal mechanisms. Consciousness of a certain decision thus appears as a lengthy process which essentially escapes control and is causally determined. In this sense, all human behavior and decisions are predetermined and caused by unconscious neurological processes and networks. Decisions are necessary consequences of neuronal courses]. In a subsequent and extreme step, the knowledge of these laws would enable us to predict or determine human behavior, giving rise to a new form of determinism, “a neurodeterminism conception”.

Speaker Biography

Tenured Assistant Professor at Faculty of Law of the University of Coimbra. Member of the Institute for Legal Research of the University of Coimbra. Member of the Scientific Committee of the Institute of Interdisciplinary Research – University of Coimbra. Senior Fellowof the Carol and Lawrence Zicklin Center for Business Ethics Research, Wharton School, University of Pennsylvania. Visiting scholar of the Max-Planck-Institut für ausländisches und internationals Strafrecht, in Freiburg (2003, 2008, 2009). Has published several articles and jurisprudence annotations (90), monographic works (4) and co-edited books (3) in the area of criminal law, economic criminal law and criminal procedural law. Has been invited as key-note speaker in several conferences and seminars, in the scope of law and criminal procedure, in Portugal and abroad.

Listen to this article

Kajal Shah

Title- Spine myeloid sarcoma

Speaker Abstract

Myeloid sarcoma (MS) is a malignant extramedullary tumor consisting of immature cells of myeloid origin. It may precede, present concurrently or follow acute myeloid leukemia (AML) in de novo case or may also be present and might be the only manifestation of recurrent AML, myelodysplastic syndrome, or chronic myeloid leukemia. It frequently involves skin, orbit, bone, periosteum, lymph nodes, and gastrointestinal tract, soft tissue, central nervous system, and testis. Because of its different localization and symptoms, and the lack of diagnostic algorithm, MS is a real diagnostic challenge particularly in patients without initial bone marrow involvement. The correct diagnosis of MS is important for optimum therapy, which is often delayed because of a high misdiagnosis rate. We reported three cases of MS derived from spine presented with back pain, paraplegia, paraparesis, respectively, and reviewed the relevant literature.

Speaker Biography

Dr. Kajal Shah is a Medical Oncologist and Hematologist and has an aim is deliver quality and compassionate care to her patients since 2012. Dr. Shah has left no stone unturned in making special efforts in accommodating individual needs of her patients. She utilizes her domain expertise and experience in providing best and state-of-the-art care by encouraging honest and transparent treatments. She is known for delivering patient centred and result oriented treatments. She uses chemotherapy, immunotherapy, hormonal therapy, targeted therapy and most importantly supportive/palliative care in an effective manner for treatment for all solid tumors as wells as hematological cancers in adults and children.

Listen to this article

Zahra Khazaeipour

Title- Association of pain, social support and socioeconomic indicators in patients with spinal cord injury in Iran

Speaker Abstract

Objectives: Pain is a prevalent complication of individuals with spinal cord injury (SCI). Our objective was to examine the association between social support, socioeconomic factors and psychosocial factors and pain to develop more effective management strategies. Setting: Brain and Spinal Cord Injury Research (BASIR) Center, Tehran University of Medical Sciences, Tehran, Iran. Methods: The Persian version of the Brief Pain Inventory was used to measure the pain, and the Multidimensional Scale of Perceived Social Support was used to measure social support through structured face-to-face interviews in SCI individuals. Results: The overall prevalence of pain was 50.7%; 79.3% of individuals had bilateral pain, with lower limbs and back being the most common location. The quality of pain was described as aching (41.4%), tingling (32.9%), pressure (15.7%), coldness (5.7%) and feeling electric shock sensations (4.3%). The frequency of pain in individuals with paraplegia (60.9% vs 45.7%) and incomplete (53.5% vs 52.5%) SCI was higher than with other types of neurological injuries. Patients with a medium level of education had the least pain and those with good economic situation reported higher frequency of having pain (P=0.034). There was no significant relationship between pain and social support. There was a positive correlation between pain and impairment of mood, normal work, relations with other people and lack of sleep (P<0.001). Conclusion: These novel findings will inform the development of strategies to manage pain by improving access to health-care facilities and supplies.

Speaker Biography

Dr ZahraKhazaeipour is Associate Professor of Preventive and Community Medicine, She completed Undergraduate medical education and Medical internship at Tehran University of Medical Sciences (1991, January - 1998, May). Then completed the Residency program (including one-year MPH program) at Shiraz University of Medical Sciences (2005, Sept - 2008, Sept). She has Iranian national board certification of Community Medicine.

Listen to this article

Sepideh Paybast

Title- Recurrence of covid-19 in a patient with NMO spectrum disorder while treating with rituximab

Speaker Abstract

Introduction: In the context of coronavirus disease 2019 (COVID-19) pandemic, patients with neuromyelitisoptica spectrum disorder (NMOSD) are vulnerable to develop COVID-19 due to the immunosuppressive therapy. The objective of this study is to describe a known case of NMOSD on rituximab who experienced 2 episodes of COVID-19. Case Report: A 25-year-old woman, a known case of NMOSD on rituximab was diagnosed with asymptomatic COVID-19. Eight months later, following her last infusion of rituximab, she developed moderate COVID-19. After a partial recovery, she exhibited exacerbation of respiratory symptoms leading to readmission and invasive oxygenation. She was eventually discharged home after 31 days. Her monthly neurological evaluation did not reveal evidence of disease activity. She later received intravenous immunoglobulin and the decision was made to start rituximab again. Conclusions:Our case raises the possibility of persistent virus shedding and reactivation of severe acute respiratory syndrome coronavirus-2 in a patient with NMOSD and rituximab therapy. We aimed to emphasize a precise consideration of the management of patients with NMOSD during the COVID-19 pandemic.

Speaker Biography

Sepideh Paybast was born in 1988 in Iran. She passed the general medicine course at the University of ShahidBeheshti, Tehran, Iran, between 2007-and 2014. Then she took a specialized course in general neurology in 2014- 2018 at the University of ShahidBeheshti. After graduation, she started her job as an assistant professor of Neurology at the University of Qazvin (2019-2020) and subsequently Qom (2020-2021). While working in Qom, Iran, she was also a member of the research center of Qom universality of medical sciences, Iran, Afterward, she participated in the MS fellowship examination at the University of Tehran, Iran. Currently she is in the final half of my MS fellowship course, and she will graduate in the next six months. Her main research interest is devoted to central nervous system demyelinating disorders.

Listen to this article

 
 16:05-16:25 Intermission & Tea Break

Suja Xaviar

Title- Calculation of the fragility index of randomized controlled trials in epilepsy published in twelve major journals

Speaker Abstract

Objective: Fragility index is the minimum number of participants in a trial whose status has to be changed from an ‘event’ to a ‘non-event’ for a dichotomous primary outcome to turn the P-value (calculated by Fischer’s exact test) statistically non-significant (P > 0.05). This study was performed to evaluate the fragility index of randomized controlled trials (RCTs) in epilepsy published in 12 major journals. Methods: We identified the relevant RCTs published in six major epilepsy-related and six Neurology journals from January 2015 to September 2019 and determined the fragility index of those RCTs which reported statistically significant results of dichotomous primary outcomes. We also calculated the Spearman correlation coefficients between the fragility index and the sample size, the event rate, and the reported P-value. Results: A total of 1395 RCTs were screened and finally ten were eligible for the analysis. The median (IQR) fragility index was only 1.5 (11). There was no significant correlation between the fragility index and the sample size (r = 0.620, P = 0.056), the event rate (r = < 0.0001, P = 1.0), and the reported P-value (r = − 0.315, P = 0.447). Conclusion: The median fragility index of the included RCTs on epilepsy was very low. The addition of only two alternate events to an arm of the average trial would have rejected the statistical significance. Fragility index should be used while reporting the results of dichotomous primary outcomes of RCTs

Speaker Biography

Dr. Suja Xaviar is presently working as senior resident in the department of Pharmacology, JIPMER, Puducherry.Areas of interest: Neuropharmacology, Pharmacovigilance, Therapeutic drug monitoring,Drug efficacy studies, Drug utilisation and audit studies. Presented papers and posters in national and international meetings.Bagged several awards for best paper presentations at national and international conferences. Reviewer of Journal of Pharmacology and Pharmacotherapeutics (JPP).Published several research papers in national and international journals

Listen to this article

 
 16:05-16:25 Intermission & Tea Break

Terrance L Baker

Title- Essential guidelines for covid-19 patient discharge instructions

Speaker Abstract

Introduction: Clinicians treating COVID-19 patients face a major challenge in developing effective communication with patients who are discharged to home in order to promote and enhance safety. The purpose of discharge instructions is to provide guidance from health care personnel involving discharging COVID-19 patients. SARS-CoV-2 positive or suspected of being positive patients discharged to home following encounters at health care facilities require specific or tailored recommendations for continued care at home to promote the safe SARS-CoV-2 recovery of themselves, their families, and others. Methods: A systematic literature-search of studies evaluating optimal performance criteria parameters was used to determine patient morbidity and mortality factors as they relate to both symptoms and signs of COVID-19. Discharge instructions were developed from 157 studies in response to the review of this broad-spectrum of literature. These instructions are key to educating patients in the parameters that require monitoring to determine disease improvement or the need for a medical reevaluation. Results: These guidelines were developed for patient education and achieve the following essential goals: assisting patients to provide a basic understanding of their medical situation; reducing the likelihood of complications by providing instructions which assist patients to know when to use available health services. Patient stress can be reduced by giving patients comfort through the understanding of how to respond to their condition changes.Conclusion: The COVID-19 has often created confusing for patients and their families. Clinicians must efficiently and effectively teach patients self-management strategies and what to expect when they return home and what to do when they experience possible changing conditions. The primary goal of the patient education discharge instructions (PED) is to provide the patient with understandable self-management strategies. These include prevention of disease transmission; prevention of complications by understanding the actions required to recover; and to know when conditions require medical reevaluation.

Speaker Biography

Terrance L. Baker, MD, MS, is board certified in family medicine, emergency medicine, and geriatrics. Dr. Baker is a graduate of George Washington University School of Medicine and holds a Master of Science degree from Johns Hopkins University. He is the medical director of Sollay Medical Center in Baltimore, Maryland. Dr. Baker is a member of the Department of Medicine at Johns Hopkins Medicine. He also holds teaching posts at the University of Maryland School of Nursing in Baltimore, and the New York University. Dr. Baker has multiple publications and has lectured in the USA and Internationally on SARS-CoV-2.

Listen to this article

 
 16:05-16:25 Intermission & Tea Break

Yong Chen

Title- Detecting memory-related gene modules and causal regulations in snRNA-seq data by deep-learning

Speaker Abstract

To understand the detailed molecular mechanisms of memory formation in engram cellsis one of the most fundamental questions in neuroscience and computational system biology. Recent single-nucleus RNA-seq (snRNA-seq) techniques have allowed us to explore the sparsely activated engram ensembles, enabling access to the molecular mechanisms that underlie experience-dependent memory formation and consolidation. However, the absence of specific and powerful computational methods to detect memory-related genes (modules) and their regulatory relationships in the snRNA-seq datasets has strictly limited the analysis of underlying mechanisms and memory coding principles in mammalian brains. We have designed a deep-learning method to detect memory-related gene modules in snRNA-seq datasets, anddesigned a deep-learning method to infer causal regulatory relationships within gene modules. We applied them on snRNA-seq datasets of TRAP; Ai14 mice brains with fear memory and detected not only known memory-related genes, but also the modules and potential causal regulations. Our results provided novel regulations within an interesting module including Arc, Bdnf, Creb, Dusp1, Rgs4 and Btg2. Overall, our methodsprovide a series ofcomputational tools for processing snRNA-seq data and delineate the regulation mechanisms underlying remote memory formation. The detected gene modules may provide potential targets and strategies for treatment of memory loss in neuron degenerative diseases. The methods can also be used to process general scRNA-seq datasets that are generated from case versus control studies.

Speaker Biography

Dr. Yong Chen is an assistant professor at the Department of Molecular and Cellular Biosciences, Rowan University, USA. He has a long-term training of mathematics and biology. His research has focused on bulk/single-cell omics studies, bioinformatics and mathematical modeling for cancer epigenetics and computational neuroscience. Current research topics include (1) designing novel experimental and computational methods to dissect 3-D chromatin interactions and how the disordered interactions (and epigenetic modifications) are associated with cancer/disease development; (2) designing deep learning methods to process and integrate single-cell omics datasets; (3) mathematical modeling the memory formation mechanism. He is an ad hoc reviewer for multiple bioinformatics journals, conferences, and federal level grants.

Listen to this article

 
 16:05-16:25 Intermission & Tea Break

Fredric Schiffer

Title- A novel, safe, effective treatment for opioid use disorder

Speaker Abstract

Schiffer has proposed and tested and published his novel hypothesis about the relation between the cerebral hemispheres and psychopathology. His ideas come out of his clinical observations and the split-brain studies and are combined in what he has termed dual-brain psychology (DBP), which posits that one brain hemisphere, left or right, as a trait in an individual is more affected by early complex traumas and he has found in his clinical practice and in two published randomized control trials that activating the healthier hemisphere with unilateral transcranial photobiomodulation (UtPBM), near infrared mode has been highly successful in treating a range of psychiatric disorders including opioid use disorder. Here we will focus on the latest NIH funded trial in which we sought to treat 39 participants mostly from CraigsList.com who reported significant opioid cravings. 19 participants were treated with an active LED and 20 with a sham, which used the identical device with foil over the LED. The study was conducted and 2 sites, both of which reported similar results. The participants were treated twice a week for 4 weeks with 3 weekly follow-ups. The results as shown in Figure 1. showed that from baseline to the 3rd follow up there was a highly significant better improvement in the active group versus the sham and at the end of treatment and at the 3rd follow-up with an effect size was 1.5. At the McLean site there was also a very significant decrease in opioid use in the active group but not sham. In Schiffer's private practice he combines this UtPBM treatment with psychotherapy based on DBP, but in this control study, participants received only a twice weekly UtPBM treatment or sham. We feel the study show that UtPBM can be used as a stand-alone treatment or in combination with buprenorphine. From private practice, we feel it is greatly augmented when combined with dual-brain psychotherapy and we feel that this randomized control trial supports the novel hypotheses of DBP from which the UtPBM evolved. There were no adverse reactions observed or reported.

Speaker Biography

Fredric Schiffer, MD, is a research associate at McLean and an assistant professor of psychiatry, part-time, at Harvard Medical School. He has been studying the relationship between past traumas, cerebral laterality, and depression, anxiety, and addiction and has developed a hypothesis on the physical nature of conscious experience and its relation to the brain and to psychological function. Dr. Schiffer also studies the role that near infrared light directed through the forehead to the brain may play as a treatment for psychological problems, including opioid use disorders. He maintains a private practice of adult psychiatry in Newton, Massachusetts and is the Founder and CEO of MindLight, LLC and the Dual-Brain Psychology Institute.

Listen to this article

 
 16:05-16:25 Intermission & Tea Break

Brandon Lucke Wold

Title- Targeting Neuroinflammation: A Novel Approach to Treating Vasospasm following Subarachnoid Hemorrhage-

Speaker Abstract

Background: Cerebral vasospasm (CV) can contribute significant morbidity for subarachnoid hemorrhage (SAH) patients. A key unknown is how CV induction is triggered following SAH. Methods: c57/bl6 wild type and c57/bl6 IL-6 female knockout (KO) mice were utilized with groups: saline injected, SAH, SAH + IL-6 blockade, SAH IL-6 KO, SAH IL-6 KO + IL-6 administration. For SAH, 50m blood was collected from tail puncture and administered into basal cisterns. IL-6 blockade was given at various time points. Various markers of neuroinflammation were measured with western blot and immunohistochemistry. Cerebral blood flow was also measured. Vasospasm was measured via cardiac injection of india-ink/gelatin. Turning test and Garcia’s modified SAH score were utilized. P<0.05 was considered significant. Results: IL-6 expression peaked 3 days following SAH (p<0.05). Human IL-6 was increased in aneurysmal blood (p<0.05). Receptor upregulation was periventricular and perivascular. A significant increase in BBB markers endothelin 1 and occludin were noted following SAH but reduced with IL-6 blockade (p<0.01). CV occurred 5 days post SAH but was absent in IL-6 KO mice and mitigated with IL-6 blockade (p<0.05). IL-6 blockade, and IL-6 KO mitigated effects of SAH on cerebral blood flow (p<0.05). SAH mice had impaired performance on turn test and poor Modified Garcia Scores compared to saline and IL-6 blockade. A distinct microglia phenotype was noted day 5 in the SAH group (overlap coefficients r=0.96 and r=0.94) for Arg1 and iNOS, which was altered by IL-6 blockade. Day 7, a significant increase in toll-like receptor 4 and Stat3 were noted. This was mitigated by IL-6 blockade and IL-6 KO, which also reduced Caspase 3 (p<0.05). Ventricular dilation and increased tunel positivity were noted day 9 but resolved by IL-6 blockade (p<0.05). Conclusion: correlation between IL-6 and CV has been well documented. We show that a mechanistic connection exists via the inflammatory response, and IL-6 blockade provides benefit in reducing CV and its consequences.

Speaker Biography

Brandon Lucke-Wold was born and raised in Colorado Springs, CO. He graduated magna cum laude with a BS in Neuroscience and distinction in honors from Baylor University. He completed his MD/PhD, Master’s in Clinical and Translational Research, and the Global Health Track at West Virginia University School of Medicine. His research focus was on traumatic brain injury, neurosurgical simulation, and stroke. At West Virginia University, he also served as a health coach for the Diabetes Prevention and Management program in Morgantown and Charleston, WV, which significantly improved health outcomes for participants. In addition to his research and public health projects, he is a co-founder of the biotechnology company Wright-Wold Scientific, the pharmaceutical company CTE cure, and was a science advocate on Capitol Hill through the Washington Fellow’s program. He has also served as president of the WVU chapters for the American Association of Pharmaceutical Scientists, Neurosurgery Interest group, and Erlenmeyer Initiative Entrepreneur group. In addition, he has served as vice president for the graduate student neuroscience interest group, Nu Rho Psi Honor Society, and medical students for global health. He was an active member of the Gold Humanism Honor Society and Alpha Omega Alpha Honor Society. He is currently a member of the UF House Staff Council and Positive Culture Committee. He is married to Noelle Lucke-Wold and has two children. As a family, they enjoy running with their dogs, rock climbing, and traveling. In his spare time, Brandon frequently runs half marathons and 10ks together with is wife. Brandon also enjoys reading and discussing philosophy and playing chess. He is currently a Pgy4 neurosurgery resident at University of Florida with R25 funding and plans to pursue endovascular training.

Listen to this article

09:00-09:15

                   Opening Ceremoney

MohamedEisa El Amin

Title- Giant middle turbinate osteoma diagnosis and management

Speaker Abstract

Sinonasal osteomas are the commonest benign tumours of the paranasal sinuses with an approximate true incidence rate between 0.014% and 3%. We present a patient with intractable frontal headache and intranasal polyposis, who was found to have a massive, complex osteoma arising within a concha bullosa. A 23 year old male presented with severe symptoms poorly responsible to medical management with rapidly progressive, associated with diplopia and imbalance. Investigations : The scan revealed a very large osteoma (59.81 mm × 33.38 mm x 32.00 mm) arising within a right-sided concha bullosa of the middle turbinate and extending into the nasopharynx was shown in CT scan. Management : The patient underwent an urgent image-guided modified endoscopic Lothrop's procedure to facilitate complete endoscopic excision thorough sinus drainage. To date, there are only 8 case reports of osteoma of the middle turbinate. We are, presenting the case where the osteoma of an aerated middle turbinate was of such a massive size. This case highlights the importance of giving common symptoms, such as headache, the required attention and consideration before dismissing them as trivial. Conclusion: The case reported herewith represents the largest known concha bullosa osteoma. It is the first to be removed entirely endoscopically. It is also the first removed via a modified endoscopic Lothrop approach. This very challenging case highlights the importance of thorough interrogation of pre-operative clinical assessment, imaging and careful planning of the surgical procedure.

Speaker Biography

Mohamed Eisa El-Amin is MBBS faculty of Medicine at University of Khartoum, completed MRCS-ENT from Royal college of Edinburgh, McH from Edge Hill University. He has done Core surgical training -ENT in Manchester UK

Listen to this article

Sundus Alusi

Title- Thalamic vs. midbrain tremor: Two distinct types of Holmes’ Tremor

Speaker Abstract

Introduction: Holmes Tremor (HT) is a unique and debilitating movement disorder. It usually results from lesions of the midbrain and its connection but can also result from posterior thalamic injury. Clinical examination can help lesion localization between these two areas. We studied the clinical features and their radiological correlations to distinguish midbrain HT (HT-m) from thalamic HT (HT-t). Methods: Retrospective review of 17 patients with a HT-type presentation was conducted. Tremor characteristics, associated clinical signs and radiological findings were studied. Results: Eleven patients had a myorythmic rest tremor, large amplitude proximal tremor with goal-directed worsening, with or without mild distal dystonic posturing, representing HT-m. Six patients had slow, large amplitude proximal tremors and distal choreathetoid movements, significant proximal/distal dystonic posturing, associated with proprioceptive sensory loss, representing HT-t. Haemorrhagic lesions were the predominant cause of HT-m; whereas, ischaemia was more commonly associated with HT-t. Conclusion: When assessing patients with HT, attentiveness to the presence of associated signs in the affected limb, such as a proprioceptive sensory deficits and additional movement disorders, can aid lesion localisation, which can have implications for management.

Speaker Biography

Sundus Alusi, MBChB, MD, FRCP, is a consultant neurologist at the Walton Centre NHS Foundation Trust, UK. She subspecialises in Movement Disorders. She has a special interest in Tremor, Huntington’s Disease, FXTAS and Deep Brain Stimulation. She has published her research in several peer reviewed journals.

Listen to this article

Mirza Muhammad Faran Ashraf Baig

Title- DNA nanotechnology for modulating the growth and development of neurons

Speaker Abstract

Objectives: DNA nanodevice was developed for the bioimaging of late prenatal growth, early postnatal growth, and layering of the neocortical neurons (NC-Ns) which play determining roles in the development of the cerebral cortex (CC). Scope: Here, we systematically explore the interactive role of neuronal surface receptors (NSRs) on cytoskeleton activation (CA) and the piconewton (pN) force generation (P-FG) and their influence on the proper development, growth, and functioning of neurons using a designed DNA nanomechanical device (DNA-NMD). Methods: The DNA-NMD, functioning as a molecular tension probe (MTP), was used to selectively bind the different NSRs (β-NGFR, Reelin, and Integrin) to mono-, bi-, and trip specifically activate the receptors on the NC-Ns surface for imaging and calculating the P-FG involved in various processes. Results: Measurements in vivo on the brain of newly born Institute of Cancer Research mice(early postnatal) or in vitro after extracting neurons from the fetal brain of pregnant Institute of Cancer Research mice (late prenatal) reveal that there are augmented interactive roles of theβ-NGFR with Integrin and Reelin receptors (RR) on the CA and P-FG. Conclusion: The DNA-NMD enhanced the cytoskeletal activations and directional migration of the neuronal endings (M-NEs), which favored layering, the somal terminal translocation (S-TT),and the early postnatal growth.

Speaker Biography

Dr. Mirza Muhammad Faran Ashraf Baig is a registered Pharmacist and currently a post-doctoral fellow at the Faculty of Dentistry, The University of Hong Kong under the supervision of Professor Chengfei Zhang. He received his Doctor of Pharmacy (PharmD) and MPhil (Pharmaceutical Chemistry) degrees from the Faculty of Pharmacy, Bahauddin Zakariya University (BZU), Multan, Pakistan, and a Ph.D. degree from the School of Chemistry and Chemical Engineering, Nanjing University (NJU), China under the supervision of Prof. Dr. Xing-Hua Xia. His research work is about Biomedical Engineering, Mechano-Pharmacology, Polymers, Material Chemistry, DNA Nanotechnology, Developmental Biology, Neuroscience, Nano-Therapeutics, Bio-sensing, Bio-imaging, Diagnostics, Biotechnology, Biophysics, and Biochemistry. His current research focus is designing DNA-based novel functional & bio-active nanomaterials to apply in Restorative Dentistry, Oral Microbiology & Oncology, Regenerative Therapeutics, Stem Cells Research, Drug Delivery, and Molecular Pharmaceutics. He published in the top journals e.g Nano Letters (ACS, USA), indexed in Harvard University Library Press.

Listen to this article

Galvan Laurie

Title- Longitudinal evaluation of striatal dysfunctions in autism spectrum disorders

Speaker Abstract

The autism spectrum disorder (ASD) is a non-lethal neurodevelopmental disorder. The adult ASD patients carry a substantial comorbidity burden leading to a “premature aging” and a reduced life expectancy. Our main question was whether this “premature aging” is a mere consequence of initial neurodevelopmental deficits or due to a cumulative pathological process. We used ex vivo electrophysiology, optogenetics, chemogenetics, behavioural assessment and neuroanatomy to characterize the dysfunctions at different ages. We focused on identifying the onset of striatal dysfunctions in mouse models of ASD. We observed a worsening in motor dysfunctions in aged ASD animals. In addition, our preliminary data showed premature morphological alterations of striatal neurons inadult ASD. In addition, our results suggest that striatal interneurons could also be dysfunctional. These results open up a new field of investigation to better understand lifelong consequences of ASD in adults.

Speaker Biography

I am an associate professor at the University of Poitiers since 2017 and part of the LNEC ( laboratoire de neurosciences experimentales et cliniques (U-1084)). I obtained my PhD in 2011 (CEA) and I completed a postdoctoral stay at UCLA from 2011 to 2016 (project scientist from 2016-2017).I have been very interested in understanding the basal ganglia network in pathological conditions both during my thesis/post doc period (Huntington's disease) and currently (Autism Spectrum Disorders). I investigate the underlying mechanisms leading to a damageable phenotype in rodent transgenic model of the disease.

Listen to this article

Maxwell Blesdel ADASSI

Title- Aqueouslyophilisate of malvaviscus arboreus dill. Ex cav.lLeaves exerts antiepileptogenic properties via a modulation of gabaergic neurotransmission, neuroinflammation and oxidative stress in rats

Speaker Abstract

Epilepsy remains one of the most challenging neurological disorders worldwide and particularly in sub-Saharan Africa, where the epilepsy treatment gap remains very high. The present study thus aimed to evaluate the antiepileptogenic properties of Malvaviscus arboreus in rats. Apart from the vehicle, animals were challenged with Pentylenetetrazole (PTZ) (70mg/kg). All the challenged animals were later divided into the treatment groups (negative control, valproate 300 mg/kg, M. arboreus 122.5, 245 and 490 mg/kg). Except the vehicle, all the other groups were subjected to kindling PTZ, consisting of repeated administration of PTZ at a dose of 35 mg/kg every other day. The percentage of protection against seizure and the seizure progression were assessed. TNFα and TGFβ1 levelswere assessed using ELISA.GABA, GABA transaminase and oxidative stress were assessed in the hippocampus using spectrophometric assay and histological analysis using cresyl-violet staining. Results showed that the aqueous extract of M. arboreus leaves at a dose of 245 mg/kg significantly increased the number of injections needed to reach the kindled state (p<0.001) and protected animals against the development of epilepsy (P<0.001). The lyophilisate significantly decreased the activity of GABA transaminase (p<0.01), the levels of TNFα (P<0.001), TGFβ1 (P<0.001) and Malondialdehyde (P<0.05), and increased the concentration of GABA (p<0.05), Reduced Glutathione (p<0.001) and Catalase (p<0.001), and also preserved the architecture of the hippocampus and prevented necrosis of neurons. The aqueous lyophilisate of the leaves of M. arboreus thus has antiepileptogenic properties and could therefore be of great benefit in the alternative and complementary therapy of epilepsy.

Speaker Biography

Maxwell ADASSI is a young scientist of Cameroonian nationality, holder of a Master of Science in Animal Physiology, specialty neurophysiology, and enrolled in the 3rd year PhD study at the University of Maroua in Cameroon. His research work focuses on the evaluation and enhancement of plants from the Cameroonian pharmacopoeia in the treatment of epilepsy and its comorbidities. He won 2 prizes from the Cameroon Association of Neurosciences (CAMANE), including the prize for the best oral presentation (2018) and the best poster presentation (2020). He also won the 3rd prize in the “my thesis in 180 seconds” competition organized by the Cameroon Biosciences Society (2019). He moreover actively participated in several editions of the Brain Awareness Week in Cameroon. This young enthusiast of everything concerning brain and its functioning, as well as phytopharmacology, is one of those who think that “when the Brain doesn’t work, the rest doesn’t matter”.

Listen to this article

Husham Bayazed

Title- Anti-β2-glycoprotein I autoantibody expression as a potential biomarker for strokes in patients with anti-phospholipid syndrome

Speaker Abstract

Anti-phospholipid syndrome (APS) is an autoimmune disease. Cerebral ischemia associated with APS occurs at a younger age than typicalatherothrombotic cerebrovascular disease and is often recurrent, This study sought to determine the frequency rates of anti-cardiolipin (aCL) dependent on the presence of β2-GPI, anti-β2-glycoprotein I (aβ2-GPI), and anti-phosphatidyl serine (aPS) IgG autoantibodies among stroke patients. Stroke patients and control subjects recruited from Mosul, Erbil, and Dohuk provinces in Northeren Iraq were evaluated. All cases were under 50 years-of-age and had no recognizable risk factors. Using ELISA, the results indicated that the frequency of aβ2-GPI was 14/50 (28%), aCL was 11/50 (22%), and aPS was 9/50 (18%) among stroke patients. In contrast, aCL was detected in 2/30 (6.7%) of control subjects; each of the other anti-phospholipid antibodies (APLA) was never observed. Of all the aβ2-GPI+ cases, the incidence of stroke patients having the combined profile of aβ2-GPI + aCL was 11/14 (78.6%) and of aβ2-GPI + aPS was 9/14 (64.3%). Only 2/14 (14.3%) of these aβ2-GPI+ patients also expressed aCL in the absence of aPS. In none of the APS/stroke patients were aCL or aPS expressed in the absence of the aβ2-GPI. Conversely, aβ2-GPI as a sole marker was seen in 3/14 (21.4%) of these patients (i.e., in absence of either other marker). It can be concluded from these studies that the among the three major forms of APLA examined, the presence of aβ2-GPI IgG autoantibodies appeared to correlate best with stroke in patients who were concurrently suffering APS.

Speaker Biography

Prof Dr.HushamBayazed has completed his PhD from University of Mosul, College of Medicine. He is now Consultant Immunologist at Scientific Research Center, University of Zakho / Kurdistan Region. He is specialist in clinical Immunology with interest in Neuro- immunology and has published more than 25 papers in reputed journals and has been serving as scientific reviewers of many local and international medical journals. In addition of being Fellowship of ISC, Infection, Cancer and Immunology Advisory Board Member (EUROMDnet) (Belgium), Membership of World Stroke Organization, Membership of Metabolomics (USA), and Membership of American Association of Science & Technology.

Listen to this article

Kajal Shah

Title- Efficacy and toxicity analysis of imatinib in newly diagnosed patients of chronic myeloid leukaemia: 18-years’ experience at a single large-volume centre

Speaker Abstract

Background: Imatinib (IM) remains a path-breaking treatment for chronic myeloidleukemia (CML). We report 18 years of experience in treating patients of CML withIM at a single large-volume center. Methods: A retrospective analysis of 158 CML adult patients who received IM from September 2002 until August 2009 was done. Response (hematologic), progression-free survival (PFS) and toxicity were evaluated. RT-PCR was established in our institute in 2011; before that, its documentation was few and far between. On progression, dose of IM was sequentially increased to 600mg and 800mg. Results: At a median follow up of 15.1 years, analysis of 132 patients was done; 26(16.7%) lost to follow-ups were excluded from the analysis. Median Age presentation was 37 (IQR 30-45), with a slight female skew (54%). The most common presentation was fatigue (41%) and abdominal fullness (23%), median haemoglobinwas 9.6 gm/dl (IQR 8.4-11.3), and total leucocyte count 92 X 103(IQR 32.2 X 103- 15.7X104). Mean time to complete haematological response (CHR) was 2.6 months (S.D+0.7 months), and complete cytogenetic response (CCyR) was documented in 81.3%.Of the analyzed, 58 (43.9%) progressed (loss of either CHR or CCyR) on IM 400, in these the dose of IM was escalated. Mean PFS on IM 400 was 146.4 months (95% CI; 131-161). On IM 600, 25 (43.1%) progressed and were started on IM 800; of these, 9(36%) progressed on IM 800mg and were shifted to second-line tyrosine kinase inhibitors (TKI). Haematological toxicity was seen in 32 (24%) patients; non-haemato-logical side effects were seen in 36 (27.3%), both most commonly in first two years. Grade III or IV side effects were rare. At the time of analysis, 6 (4.6%) had progressed to blast crisis. Conclusions: This 15.1-year median follow up has shown that IM is a highly effective and safe drug for first-line treatment of CML-CP. It is phenomenal in inducing CHR andCCyR with a safety profile to envy. For patients progressing on IM 400, the dose consequentially and subsequently be increased to 600 and 800, with acceptable toxicity. This data should benefit low- and middle-income countries where second-generation TKIs are not a financially feasible option upfront.

Speaker Biography

Dr. Kajal Shah is a Medical Oncologist and Haematologist and has an aim is deliver quality and compassionate care to her patients since 2012. Dr. Shah has left no stone unturned in making special efforts in accommodating individual needs of her patients. She utilizes her domain expertise and experience in providing best and state-of-the-art care by encouraging honest and transparent treatments. She is known for delivering patient centred and result oriented treatments. She uses chemotherapy, immunotherapy, hormonal therapy, targeted therapy and most importantly supportive/palliative care in an effective manner for treatment for all solid tumors as wells as haematological cancers in adults and children. Area of Interest: a. DM student education b. Medical oncology Clinical research and clinical trials c. Tumor board discussion d. Participate in national and international oncology conferences e. Treating patients of solid and hematolymphoid malignancy with Chemotherapy, Immunotherapy, Targeted therapy, hormonal treatment and palliative care.

Listen to this article

 
 13:10-14:00 Intermission & Lunch Break

Turyalai Hakimi

Title- Bilateral open lip Schizencephaly

Speaker Abstract

Schizencephaly is a central nervous system (CNS) developmental disorder characterized by abnormal cleft extending from the lateral ventricles to the cerebral cortex. Clinically, it occurs as trans-mantle, closed lip and open lip types which may be unilateral or bilateral. The exact cause of schizencephaly is not known but genetic disorders, exposure to teratogens, viral infections and maternal age are implicated. We present a case of bilateral open lip schizencephaly with some degrees of neurological disorders caused by increased intra-cranial pressure (ICP) due to ventriculomegaly. We applied ventriculo-peritoneal shunt (V–P shunt) to the patient with considerable improvement after post-operative follow-up.

Speaker Biography

Turyalai Hakimi is an associate professor and Head department of pediatric surgery, Kabul University of medical science, Maiwand teaching hospital. He is PEER REVIWER (Baishideng Publishing Group Inc: Pleasanton, CA, US). He has over 23 research papers in the national and international journals

Listen to this article

Sakineh Soltani Kouhbanani

Title- Physical activity affect executive functions in children with attention deficit disorder: A randomized, controlled trial with 3-month follow-up

Speaker Abstract

Objectives: Since few studies have explored the impact of Physical Activity on cognitive functions in children with Attention Deficit/ Disorder (ADD), this study is designed to evaluate the impact Physical Activity training Affect executive functions in children with ADD. Methods: sample of 60 children with ADD in the age range of 10 to 14 years were randomized into a 16-week Physical Activity training (n = 30) or control group (n = 30. ). Also, the participants were followed up after 3months Physical Activity Results:significantly benefited performance in EF in post-test and follow-up, particularly in omission errors, commission errors, and reaction time (p<0.05). also, the results showed that switching attention just significantly improved in post-test, in perseverative error, non-perseverative error, and total error (p<0.05). conclusion :Findings support Physical Activity on attention difficulties in in children with ADD.

Speaker Biography

Listen to this article

Nouf Alsuwaida

Title- Teaching reflection of using technology tools in art and design courses with students of disability

Speaker Abstract

Speech disorders can affect students who attend university or colleges. They have difficulty communicating with regular students or teachers, especially face-to-face classrooms. Speech is one of the main ways students communicate their thoughts, feelings, and ideas with peers and teachers. However, Learning becomes successful with quality teaching. Technology is an effective tool for teaching students with diverse needs. It may be quite supportive in combining different approaches in lessons and addressing various intelligence of the students. With the advancement in technology, it has become easier for a teacher of the 21st century toincorporate different learning styles in a lesson. Such lessons facilitate students in acquiring knowledge according to their individual needs. It is an important aspect of diverse student populations that must be given particular attention to the students with special needs. In such a classroom scenario, where a teacher has students with special needs and other students, he must be sensible enough to make special arrangements for the students with special needs to make their learning process smooth and useful. Learning technology is the best way for students with special needs. This article explores the challenges experienced by a faculty member as she taught her online Art & Design courses to students of disabilities. The study highlights how distance learning encourages students with special needs after teaching Art online courses with regular students. Utilizing an autoethnographic approach to examining her online courses, the author reflects on the challenges and successes experienced in designing and delivering an online environment. The instructor use technology to communicate with students with special needs. Recommendations are given for practical ways other Art & Design faculty can also build online classrooms that promote student of disability engagement and interactions using technology tools.

Speaker Biography

Dr. Nouf Alsuwaida is an assistant professor at the University of Hail in Saudi Arabia. Her doctoral studies focus on Educational Learning Technologies in the field of Art and Design at New Mexico State University in the United States. Nouf’s teaching experience includes fashion design, textiles, Art and social media, Graphic Design, and the history of heritage in Saudi Arabia at the General Organization for Technical and Vocational Training, Princess Nora Bent Abdul Rahman University, and the University of Hail in Saudi Arabia. Her research interests are in women’s education issues, women’s traditional textiles and fashion, teaching and learning in art and design, social media in the curriculum, and technology theories in pedagogy.

Listen to this article

Hossein Akbarialiabad

Title- Intersection of the digital phenotyping and digital neuromarketing? A threat or an oppurtunity?

Speaker Abstract

The new era of digitalized knowledge and information technology (IT) has improved efficiency in all medical fields, and digital health solutions are becoming the norm. There has also been an upsurge in utilizing digital solutions during the COVID-19 pandemic to address the unmet mental healthcare needs, especially for those unable to afford in-person office-based therapy sessions or those living in remote rural areas with limited access to mental healthcare providers. Despite these benefits, there are significant concerns regarding the widespread use of such technologies in the healthcare system. A few of those concerns are a potential breach in the patients' privacy, confidentiality, and the agency of patients being at risk of getting used for marketing or data harnessing purposes. Digital phenotyping aims to detect and categorize an individual's behavior, activities, interests, and psychological features to properly customize future communications or mental care for that individual. Neuromarketing seeks to investigate an individual's neuronal response(s) (cortical and subcortical autonomic) characteristics and uses this data to direct the person into purchasing merchandise of interest, or shaping individual's opinion in consumer, social or political decision making, etc. This commentary's primary concern is the intersection of these two concepts that would be an inevitable threat, more so, in the post-COVID era when disparities would be exaggerated globally. We also addressed the potential “dark web” applications in this intersection, worsening the crisis. We intend to raise attention toward this new threat, as the impacts might be more damming in low-income settings or/with vulnerable populations. Legal, health ethics, and government regulatory processes looking at broader impacts of digital marketing need to be in place.

Speaker Biography

Dr. Hossein Akbarialiabad M.D.M.Sc. has been involved in multi-disciplinary research in the areas of global/public health, mentorship in academic medicine, mental health and digital health( digital phenotyping and artificial intelligence). He has recently focused on studying neuro-oncological problems associated with less known conditions such as space missions, and Antarctica (south pole).

Listen to this article

T S L Radhika

Title- Numerical models for blood flow in carotid arteries

Speaker Abstract

It is known that cardiovascular diseases are the major contributor to deaths every year worldwide. Most of these are due to atherosclerosis, a disease in which plaque builds up inside the arteries in the heart, brain, arms, legs, pelvis or kidneys, thus, leading to the development of Coronary heart disease, Carotid heart disease, Peripheral heart disease, chronic kidney disease. In this talk, I present our work on the blood flow dynamics in a diseased human coronary artery caused due to atherosclerosis. This study is essential, particularly in the current situation where COVID-19 has affected the majority of the population across the globe, and studies have revealed that COVID-19 patients are more at risk for the occlusions in arteries and veins [1]. In our work, we developed numerical models using idealized geometry for the carotid artery with Newtonian and non-Newtonian models for blood.

Speaker Biography

Dr. T S L Radhika is working as an Assistant Professor in the Department of Mathematics at BITS Pilani, Hyderabad campus. She has a rich teaching experience of 25 years and has to her credit of publishing 25+ papers in various national and international journals. Dr. T S L Radhika works in the area of Fluid mechanics. Her earlier works include the flow of non-Newtonian fluid past porous Spheroidal bodies and Spheroidal shells. She is currently working on semi-analytical solutions to fluid flow problems in flexible circular pipes with blood flow applications in the human circulatory system. Her other areas of interest include flow in curved pipes and heat and fluid flow past axisymmetric bodies in non-Cartesian coordinate systems like Spheroidal and Bipolar. She has co-authored a book on “Approximate methods for solving Ordinary Differential equations”, published by CRC Press, Taylor and Francis Group, Boca Raton, 2015.

Listen to this article

 
 16:05-16:25 Intermission & Tea Break

Vida Esmaeili

Title- Automatic micro-expression apex spotting using Cubic-LBP

Speaker Abstract

The main way to communicate is through non-verbal expressions, although it could totally bemanipulated by the person to give false expression. Unlike ordinary facial expressions, facial micro-expression has characterized by subtle movement and short duration of appearance which unleashes the true expression beyond the control of the person. Due to the nature of micro-expression which is very brief in time and low in intensity, prevalent methods could not come up with its challenges. One of the well-known dynamic texture descriptors is Local Binary Patterns on Three Orthogonal Planes (LBP-TOP) which mainly lacks in grabbing most vital information. To address this issue in this paper, we propose a novel feature extractor called Cubic-LBP that computes LBP on fifteen introduced planes. We demonstrate the effectiveness of these planes to find the apex frame where maximum facial movements within video sequences have occurred. Moreover, the whole process of spotting the apex frame in this paper is done automatically. Achieving results of apex frame spotting is satisfying on CASME and CASME II databases in comparison with most relevant state-of the-art methods

Speaker Biography

Vida Esmaeili received her B.S. degree in electrical engineering from the Azad University of Abhar, Iran, in 2015 and the M.S. degree in electrical engineering from the Azad University of Qazvin, Iran, in 2018. Since 2019, she has been working toward a Ph.D. degree in communication at Tabriz University, Iran. Her research interests include the area of image processing, machine learning, pattern recognition, and quantum communication.

Listen to this article

 
 16:05-16:25 Intermission & Tea Break

Michal Schwartz

Title- A novel approach to defeat Alzheimer’s disease: Empowering the immune system to mobilize monocyte-derived macrophages

Speaker Abstract

Neurodegenerative diseases in general, and Alzheimer’s disease (AD) in particular, are associated with multiple factors that contribute to disease escalation. Using immunological and immunogenomic tools, we described how aging of the immune system affects manifestation and progression of neurodegenerative diseases, which led us to envision that boosting the immune system might help supporting the brain. We found that one way to achieve this effect is by modestly reducing the restraints that are imposed on the immune system by the inhibitory immune checkpoint PD-1/PD-L1 pathway. Using this approach facilitated mobilization of bone- marrow derived macrophages to the diseased brain in animal models of amyloidosis and tauopathy. Systemic blocking CCR2, the chemokine receptor for monocytes migration, abrogated the beneficial effect. Transcriptomic profile of the MDM, using single cell RNA Seq revealed that they express molecules associated with anti-inflammatory activity, and scavenger receptors that can uniquely remove the intermediate toxic forms of misfolded proteins, dead cells, and cell debris, and thereby rescue synapses and brain function. We further found that the treatment was also effective in Trem2-deficient 5xFAD mice, which exhibited improvement of cognitive performance, reduced inflammation, and reduction of the amyloid beta oligomers, though not the plaques. Overall, our results indicate that targeting systemic rather than brain- specific disease-escalating factors provides a potential multi-dimensional disease-modifying therapeutic for AD and dementia, regardless of the primary disease etiology.

Speaker Biography

Listen to this article

 
 16:05-16:25 Intermission & Tea Break

Faezeh Soveyzi

Title- The role of using Zebrafish model in spinal cord injury

Speaker Abstract

Given the significant prevalence of spinal cord injury in developed and developing societies and the involvement of all age groups, finding a new way to treat it is of interest to everyone. According to the World Health Organization, 250,000 to 500,000 people suffer from this problem every year, and this problem reduces their quality of life and increases their mortality. At present, the role of cell therapy and the use of stem cell types as reconstructive medicine in the treatment of damaged tissues is like spinal cord a new phenomenon. Nowadays, Zebrafish has been discussed to be used as a new and possibly the most effective approach in the treatment of spinal cord injuries. One of the reasons that makes this model superior to other conventional models is the ability of Zebrafish in repairs related to nerve injuries. The ability of axons to regrow rapidly after injury, the absence of permanent scarring, and no existence of immune rejection after transplantation are cases that strongly support this opinion. Zebrafish cells are in small size, growth rapidly and their genomes are very similar to the human genome that makes them suitable for research in this area. Also, the advanced cognitive behaviours of this animal are amazing. There is no need to use drugs that reduce the immune system in Zebrafish model due to absence of immune rejection unlike other animal models. Therefore, these advanced features and significant superiorities in Zebrafish model should be further researched so that it can be used to discover the secrets of repairing spinal cord injuries.

Speaker Biography

Faezeh Soveyzi is 24 years old, born in Mashhad, Iran. She is a medical intern at Tehran University of Medical sciences. In addition to study medicine and working at the clinic, she is very interested in research, so from the beginning of medicine, she worked in various fields and had a special interest in neurosurgery. That's why she started research at the University-affiliated Cell Therapy and Regenerative Medicine Research Centre. In this center, they tried to first do the necessary studies on new issues in the field of neurosurgery and then write an article about the best idea. She wishes to take a big step towards healing patients with spinal cord injuries.

Listen to this article

+1-778-244-7702